Largest Company end of October 2026?
87%NVIDIA
- NVIDIA87%▲ 5
- Apple12%▼ 4
- Alphabet<1%
6 more
- Tesla<1%
- Saudi Aramco<1%
- Broadcom<1%
- Microsoft<1%
- Amazon<1%
- SpaceX<1%
Install
Thermo Fisher (TMO) Q3 organic revenue growth (non-GAAP)?
The last odds before it closed
6.98%median
0%10%
Median 6.98%Middle half 6.47% – 7.49%
How the odds have moved
Median: 5.09% on Oct 20, 6.98% now.
The median the market implied over time and its middle half (the band), read from every strike's prices on Polymarket.
Every outcome
| Outcome | Chance | Day | Bid | Ask | Pays | Traded |
|---|---|---|---|---|---|---|
| <2% | <1% | ▼ 5 | 0¢ | $1.6K | ||
| 2% to 4% | <1% | ▼ 11 | 0¢ | $494 | ||
| 4% to 6% | 2% | ▼ 59 | 0¢ | 4¢ | $27.78 | $1.6K |
| 6% to 8% | 98% | ▲ 77 | 96¢ | 100¢ | $2.1K | |
| 8%+ | <1% | ▼ 5 | 0¢ | $389 |
"Pays" is what a $1 stake returns if that outcome happens, at the price shown (before any fees). Bid and ask are the best prices to sell and buy "Yes".
The news: Thermo Fisher, GAAP
Search ›-
Global DNA Sequencing in Drug Discovery Market Report 2026 | Capitalize on 12.5% CAGR as Illumina, Thermo Fisher, QIAGEN, and Oxford Nanopore Accelerate AI-Driven Precision R&DDublin, Oct. 26, 2026 (GLOBE NEWSWIRE) -- "Deoxyribonucleic Acid (DNA) Sequencing in Drug Discovery Market Report 2026" has been added to ResearchAndMarkets.com's offering. DNA Sequencing in Drug Discovery Market to Reach $15.22 Billion by… - Cell and Gene Therapy Contract Research Organization Market Report 2026 | Capitalize on 12.3% CAGR as Thermo Fisher, IQVIA, Labcorp, ICON, and WuXi AppTec Scale Integrated TrialsDublin, Oct. 26, 2026 (GLOBE NEWSWIRE) -- "Cell and Gene Therapy Contract Research Organization Market Report 2026" has been added to ResearchAndMarkets.com's offering. Cell and Gene Therapy Contract Research Organization Market to Reach…
-
Thermo Fisher Scientific (NYSE:TMO) Price Target Raised to $810.00Posted by Tristan Rich on Oct 25th, 2026 Thermo Fisher Scientific (NYSE:TMO – Free Report) had its price target upped by TD Cowen from $760.00 to $810.00 in a research report released on Thursday,Benzinga reports. They currently have a buy… -
Orosur Mining Inc. GAAP EPS of $0.00Orosur Mining reports Q1 GAAP EPS of $0.00 and cash of $16.84M after fundraising. - Orosur Mining Inc. press release (OMI:CA): Q1 GAAP EPS of $0.00. - On August 31, 2026, the Company had a cash balance of $7,841,000 (May 31, 2026… - C&F Financial Non-GAAP EPS of $2.55C&F Financial reports Q3 non-GAAP EPS of $2.55 as adjusted net income rose 13.1% in 2026. - C&F Financial press release (CFFI): Q3 Non-GAAP EPS of $2.55. - net income for the first nine months of 2026 were the effects of the sale of an…
- Banco Latinoamericano GAAP EPS of $1.48, revenue of $99.1MBanco Latinoamericano press release (BLX): Q3 GAAP EPS of $1.48. Revenue of $99.1M (+19.7% Y/Y). Share -1.20% - Banco Latinoamericano press release (BLX): Q3 GAAP EPS of $1.48. More on Banco Latinoamericano
- Mission Bancorp GAAP EPS of $3.05, revenue of $23.4MMission Bancorp press release (MSBC): Q3 GAAP EPS of $3.05. Revenue of $23.4M (+7.1% Y/Y). - Mission Bancorp press release (MSBC): Q3 GAAP EPS of $3.05. More on Mission Bancorp
- Endeavor Bancorp GAAP EPS of $0.44, revenue of $9.35MRead Endeavor Bancorp’s Q3 results: GAAP EPS of $0.44 and revenue of $9.35M. - Endeavor Bancorp press release (EDVR): Q3 GAAP EPS of $0.44. More on Endeavor Bancorp
- German American Bancorp GAAP EPS of $1.03, revenue of $102MGerman American Bancorp reports Q3 GAAP EPS of $1.03 and $102M revenue. - German American Bancorp press release (GABC): Q3 GAAP EPS of $1.03. More on German American Bancorp
- SL Science Holding Limited Non-GAAP EPS of $0.00, revenue of $1.38BSL Science Holding Limited press release (SLBT): 1H Non-GAAP EPS of $0.00. - SL Science Holding Limited press release (SLBT): 1H Non-GAAP EPS of $0.00. More on SL Science Holding Limited
- PDL Community GAAP EPS of $0.76, revenue of $34.84M(PDLB:NASDAQ) - PDL Community press release (PDLB): Q3 GAAP EPS of $0.76. More on PDL Community
- TMO Q3 deep dive: pharma demand, AI integration, and end-market recovery drive momentumLife sciences company Thermo Fisher (NYSE: TMO) reported Q3 2026 results beating Wall Street’s revenue expectations, with sales up 9.1% year on year to $12.14 billion. Its non-GAAP profit of $6.68 per share was 4.3% above analysts’…
Related markets
All companies ›The Cheesecake Factory comparable restaurant sales in Q3 (comparable restaurant sales in Q3 2026)
11.35%median
3%12.5%
Median 11.35%
Lowe's customer transactions in Q3 2026
182.85Mhigh with an even chance
Traders see an even chance of trading as high as 182.85M.
- Reaches 178.00M98%
- Reaches 179.00M97%
Largest Company end of December 2026?
65%NVIDIA
- NVIDIA65%▲ 2
- Apple33%▼ 1
- Alphabet2%
5 more
- Microsoft<1%
- SpaceX<1%
- Tesla<1%
- Saudi Aramco<1%
- Amazon<1%
Target transactions change in Q3 2026
3.32%median
-2.5%11.5%
Median 3.32%Middle half 1.93% – 4.48%
Another critical Cloudflare incident by...?
99%October 31
- October 3199%▲ 1
- November 3099%▲ 1
- December 3199%▲ 14
Odds are traders' prices on Kalshi, Polymarket, ForecastEx and Crypto.com, not forecasts by 4Conservative. Prices read from the venues 3 min ago. Prices may be delayed. Money traded on Kalshi and ForecastEx is estimated from contracts. Not betting or investment advice.
Prediction-market prices are what traders pay for each outcome on Kalshi, Polymarket, ForecastEx and Crypto.com, read as the market's implied chance. They are not forecasts by 4Conservative, can move fast and can be wrong; they are read every few minutes and may be delayed. Money traded on Kalshi and ForecastEx is estimated from contracts at their price. News comes from the 4Conservative index; prices of stocks, rates and coins from 4Conservative Finance. Nothing here is betting, financial or investment advice. Terms of use. How to use Predictions